• -
5 Results
Seeds and flower of marijuana with gavel
Baker Briefing: Future of Federal Cannabis Reform
Over half of all Americans live in a state where cannabis is legalized. And yet, the federal government has not reclassified marijuana since 1970. According to the Controlled Substances Act, it is considered a “Schedule 1” substance — the same classification as heroin and crack cocaine with no accepted medical use.
Victoria Jupp, Gary J. Hale, Lisa Pittman February 9, 2024
A stethoscope on American paper currency.
Baker Briefing: The High Costs of US Health Care
Health care costs in the U.S. have climbed dramatically in recent decades. Elevated prescription and premium prices have left more Americans at risk of being unable to afford basic health care services. Our experts discuss key factors leading to medical unaffordability and steps policymakers must take to address the issue.
Joe Barnes, Elena M. Marks December 19, 2023
Woman Bills
Baker Briefing: Consumer Trends in a Post-pandemic Economy
The pandemic spurred a rollercoaster of quick, subsequent economic events in three years that might normally occur across three decades: record unemployment, a brief recession, federal assistance, highest inflation since the 1980s, interest rate increases, and in 2023, concerns regarding a looming recession. Some U.S. consumers have dealt with the aftermath of this whiplash by shifting their spending and saving behaviors. Our experts discuss U.S. consumer trends since the pandemic — what’s stayed the same, new phenomena, and notable policy developments. 
David M. Satterfield, Joe Barnes, Joyce Beebe, John W. Diamond March 1, 2023